News

Financial terms of the agreement have not been disclosed. PVX-410, the first vaccine developed from this technology, is designed to target multiple myeloma cells. A Phase 1/2a trial,

The payment is a part of $21m DARPA milestone awards to be earned by Medicago under a technology investment agreement to demonstrate the scalable manufacturing of its plant-expressed

The product is developed for use in the reduction of risk of preterm birth in women with a singleton gestation and a short uterine cervical length in the

TL-118 is an oral solution that targets different, non-overlapping aspects of the angiogenic process, inhibiting new blood vessel formations in tumors. The trial will include 80 patients with

ThermoDox is a proprietary heat-activated liposomal encapsulation of doxorubicin, used for the treatment of colorectal liver metastases (CRLM). The randomized multicenter Phase II study is anticipated to enroll

The Phase I of QLF project will be the construction of the pre-extraction plant which is ecpected to get completed by the end of 2012. The new pre-extraction

Bydureon, once-weekly treatment for type 2 diabetes, was approved by FDA as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

If the sNDA is approved, Truvada would be the first agent indicated for uninfected individuals to reduce the risk of acquiring HIV, the company said. The sNDA is

As of the expiration of the offer, 77,532,611 shares of common stock of Inhibitex were validly tendered and not withdrawn in the tender offer, the company said. Approximately